1 – 29 of 29
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
A Systematic Review of Heterogeneity in Outcome Definition and Reporting in Localised Renal Cancer
(
- Contribution to journal › Scientific review
-
Mark
The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma
(
- Contribution to journal › Article
- 2022
-
Mark
European Association of Urology Guidelines on Renal Cell Carcinoma : The 2022 Update
(
- Contribution to journal › Scientific review
-
Mark
2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
Plasma and Urine Free Glycosaminoglycans as Monitoring Biomarkers in Nonmetastatic Renal Cell Carcinoma—A Prospective Cohort Study
(
- Contribution to journal › Article
- 2021
-
Mark
Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Nivolumab plus Cabozantinib Joins Immune Checkpoint Inhibition Combination Therapies for Treatment-naïve Metastatic Clear-Cell Renal Cell Carcinoma
(
- Contribution to journal › Article
-
Mark
The 2021 Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Immune Checkpoint Inhibitor–based Combination Therapies for Treatment-naive Metastatic Clear-cell Renal Cell Carcinoma Are Standard of Care
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
The Impact of Histological Subtype on the Incidence, Timing, and Patterns of Recurrence in Patients with Renal Cell Carcinoma After Surgery-Results from RECUR Consortium
(
- Contribution to journal › Article
-
Mark
Novel Liquid Biomarkers and Innovative Imaging for Kidney Cancer Diagnosis : What Can Be Implemented in Our Practice Today? A Systematic Review of the Literature
(
- Contribution to journal › Scientific review
-
Mark
Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
(
- Contribution to journal › Article
- 2020
-
Mark
Features of increased malignancy in eosinophilic clear cell renal cell carcinoma
(
- Contribution to journal › Article
- 2019
-
Mark
Increased use of cross-sectional imaging for follow-up does not improve post-recurrence survival of surgically treated initially localized R.C.C. : results from a European multicenter database (R.E.C.U.R.)
(
- Contribution to journal › Article
-
Mark
Updated European Association of Urology Guidelines on Renal Cell Carcinoma : Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
(
- Contribution to journal › Article
- 2018
-
Mark
Updated European Association of Urology Guidelines : Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
(
- Contribution to journal › Article
-
Mark
Metastases from Renal Cell Carcinoma. Recurrence Patterns, Detection and Management.
(
- Thesis › Doctoral thesis (compilation)
- 2017
-
Mark
Cell-Type-Specific Gene Programs of the Normal Human Nephron Define Kidney Cancer Subtypes
(
- Contribution to journal › Article
-
Mark
Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages
(
- Contribution to journal › Article
- 2016
-
Mark
Metastasis therapies for renal cancer
(
- Contribution to journal › Scientific review
- 2015
-
Mark
Alcohol consumption and the risk of renal cancers in the European prospective investigation into cancer and nutrition (EPIC)
(
- Contribution to journal › Article
- 2012
-
Mark
TGF-B signaling in Neuroblastoma and Renal Cell Carcinoma
(
- Thesis › Doctoral thesis (compilation)
- 2011
-
Mark
Familial Renal Cell Carcinoma from the Swedish Family-Cancer Database
(
- Contribution to journal › Article
- 2009
-
Mark
A prospective analysis of the association between macronutrient intake and renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition
(
- Contribution to journal › Article
- 2007
-
Mark
Insulin-like Growth Factor System: functional role and regulation in carcinomas
(
- Thesis › Doctoral thesis (compilation)
- 2006
-
Mark
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe
(
- Contribution to journal › Article
- 2005
-
Mark
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation
(
- Contribution to journal › Article
- 2004
-
Mark
Retinoblastoma protein in human renal cell carcinoma in relation to alterations in G1/S regulatory proteins
(
- Contribution to journal › Article
- 2002
-
Mark
Cyclin E and P27 protein content in human renal cell carcinoma: Clinical outcome and associations with cyclin D
(
- Contribution to journal › Article
- 1996
-
Mark
Cytogenetic studies of normal kidney tissue and renal cell carcinoma
1996)(
- Thesis › Doctoral thesis (compilation)